高级检索

    固肾安胎丸联合黄体酮胶囊治疗先兆流产患者对其血清抑制素A、β-HCG及PRL水平的影响

    • 摘要: 探究固肾安胎丸联合黄体酮胶囊用于治疗先兆流产的临床疗效及其对患者血清抑制素A、β-HCG及PRL水平的影响。方法:选择2015年9月-2017年9月来我院进行治疗的10例先兆流产患者,随机分为研究组和对照组。对照组给予黄体酮胶囊进行治疗,研究组给予固肾安胎丸联合黄体酮胶囊进行治疗。观察两组患者的治疗有效率、血清中血清抑制素A、β-HCG、PRL及孕酮水平的影响。结果:研究组的治疗有效率为92.73%显著高于对照组72.73%(P<0.05);治疗1周,治疗2周及治疗3周后,两组患者的血清抑制素A水平显著均显著提高(P<0.05),且研究组水平显著高于对照组(P<0.05);治疗后,两组患者的孕酮、β-HCG和PRL水平均显著(P<0.05),且研究组对照组(P<0.05)。结论:固肾安胎丸联合黄体酮胶囊能够有效治疗先兆流产,通过上调血清抑制素A、β-HCG及PRL水平,进而起到固胎的作用,提高临床疗效,值得在临床上推广。

       

      Abstract: To explore the effect of the gushenantai pills combined with progesterone capsule on the treatment of threatened abortion and its effects on the levels of serum statin A,β-HCG and PRL.Method:Selected 110 patients with threatened abortion who had been treated in our hospital from Sep 2015 to Sep 2017, and equally divided them into the control group and the study group. The study group was treated with gushenantai pills combined with progesterone capsule, while the control group was treated with progesterone capsule. To explore therapeutic efficiency and the serum levels of inhibin A, β-HCG,PRL and progesterone.Results: The therapeutic efficiency in the study group was 92.73%, that was higher than that in the control group 72.73%(P<0.05); One, two and three weeks after the treatment, the inhibin A in both groups were significant increased(P<0.05), and the level in the study was higher than that in the control group(P<0.05); What’s more, the levels of β-HCG, PRL and progesterone in both groups were significant increased(P<0.05), and the levels in study group were significant higher than that in the control group(P<0.05). Conclusion: The gushenantai pills combined with progesterone capsule can effect treat the threatened abortion, through increasing the serum inhibin,β-HCG and PRL, which is worth promoted clinically

       

    /

    返回文章
    返回